Where does Alfred Scheidegger work?

Alfred Scheidegger is Managing Partner at Nextech Invest and Board director at Cleave Biosciences.

What check size does Alfred Scheidegger write?

Alfred Scheidegger typically writes checks of $100K – $5M.

What boards does Alfred Scheidegger sit on?

Alfred Scheidegger holds tracked board seats at Cleave Biosciences.

Where did Alfred Scheidegger go to school?

Alfred Scheidegger studied at Harvard Business School (The General Manager, Business Administration and Management); Kyoto University (Postdoc in Enzymology); Biozentrum, University of Basel (Doctor of Philosophy (PhD), Biochemistry and Microbiology).

Alfred Scheidegger

Investor

Managing Partner at Nextech Invest · Board director at Cleave Biosciences

Zurich

Writes $100K – $5M checks · typically $1.5M

Find your path to Alfred

212 people in our graph share verified history with Alfred — schools, employers, funds. One of them is your warm intro.

Neil RimerunlockedAlfred: together at Harvard Business School (1989)

×8Alfred: together at Harvard Business School

Alfred: together at Nextech Invest Ltd.

×2Alfred: together at Kyoto University

About

Alfred Scheidegger is co-founder and chairman of Lipovectra Inc. He founded and scaled an international venture capital firm and has served as CEO, chairman, and board member across numerous international companies focused on high-growth and innovation sectors including technology, pharma, and biotech. Scheidegger has experience in capital raising, corporate strategy, and operational leadership across Europe, Asia, and the United States, and is fluent in German and English with proficiency in Italian, Japanese, and French.

Board director at Cleave Biosciences

Intro paths

→

In turn, Alfred can intro founders to Cleave Biosciences's investors below.

Cleave Biosciences's investors · 8

5AM VenturesBoston · $100K – $4M checks Astellas Venture Management LLCSouth San Francisco · $200K – $5M checks Clarus VenturesMenlo Park New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks Nextech InvestZurich · $648K – $3.2M checks · since 2016 OrbiMedNew York · $1M – $75M checks Osage University PartnersBala Cynwyd US Venture PartnersMenlo Park · $500K – $10M checks

Experience

Lipovectra Inc.Co-Founder, Chairman of the Board of Directorcurrent2025 — present
BioNeex UGMember of the Advisory Boardcurrent2024 — present
KeliomicsAdvisor2024 — 2026Портленд, OR
Wemedoo AGChairman of the Board of Directors2023 — 2026
Nextech Invest Ltd.Founder, Managing Partner, Member of the Board of Directors1998 — 2025Zurich, Switzerland
Dottikon Exclusive Synthesis AGVice Chairman of the Board of Directors2011 — 2024Dottikon, Switzerland
Kura Kura International Ltd.Senior Advisor2021 — 2022Singapore
Rising Tide Foundation GroupMember of the Foundation Board2017 — 2021Schaffhausen, Switzerland
Cleave Biosciences, Inc.Member of the Board Of Directors2016 — 2019Burlingame, USA
MolecularMDObserver of the Board of Directors2012 — 2016Portland, OR, USA
Palyon Medical CorporationMember of the Board of Directors2009 — 2015Санта-Моника, CA
TRACON PharmaceuticalsMember of the Board of Directors2012 — 2015San Diego, CA, USA
Tetralogic PharmaceuticalsObserver of the Board of Directors2012 — 2013Malvern, PA, USA
MacroGenics, Inc.Observer of the Board of Directors2012 — 2013Rockville, MD, USA
The Genetics CompanyChairman of the Board of Directors2003 — 2013Zürich, Schweiz
ImVisioN Therapeutics Inc.Observer of the Board of Directors2008 — 2012Muttenz, Basel-Landschaft, Schweiz
Ganymed Pharmaceuticals AGMember of the Board of Directors2006 — 2008Mainz, Germany
Agensys, Inc.Observer of the Board of Directors2007Santa Monica, CA, USA
>>venture>> | Companies for tomorrowCo-Founder, Member of the Project Team, Member of the Jury1997 — 2007Zurich, Switzerland
BioVision AGMember of the Supervisory Board2003 — 2005Hannover, Niedersachsen, Deutschland
ETH ZurichAdministrative Director, Member of the Board1995 — 1998Zurich, Switzerland
CSCS Swiss National Supercomputing CenterChief Executive Officer1992 — 1995Manno, TI, Switzerland
International Science Club of Osaka, JapanDelegate of Ciba Geigy (Japan) Ltd. (today Novartis)1990 — 1991Osaka, Japan
Industrial Science and Technology, Swiss Chamber of Commerce and Industry in JapanCo-Founder and Chairman of the Committee1990 — 1991Tokyo, Japan
Ciba Geigy (Japan) Ltd. (today Novartis)Project Leader Drug Discovery1987 — 1991Basel, Switzerland and Takarazuka, Japan

Skills & more

Venture Capital2BiotechnologyCorporate DevelopmentLifesciencesCommercializationTechnology TransferStart-ups9Mergers & AcquisitionsM&A experiencePrivate Equity3IPOClinical Development

+12 more

Due DiligenceMedical DevicesGrowth CapitalBusiness StrategyStrategyValuationVenture FinancingPharmaceutical IndustryRisikokapitalPharmaindustriePrivates EigenkapitalFusionen und Übernahmen

Languages English · French · German · Italian · Japanese

From Alfred's professional profile.

Deals · 1

Cleave BiosciencesBoard seat

via Nextech Invest · filed Aug 2016 · $36.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Nextech Invest

Jakob Loven

Partner at Nextech Invest

William G. Kaelin

Science Partner at Nextech Invest

Frequently asked questions

Who is Alfred Scheidegger?: Alfred Scheidegger is co-founder and chairman of Lipovectra Inc. He founded and scaled an international venture capital firm and has served as CEO, chairman, and board member across numerous international companies focused on high-growth and innovation sectors including technology, pharma, and biotech. Scheidegger has experience in capital raising, corporate strategy, and operational leadership across Europe, Asia, and the United States, and is fluent in German and English with proficiency in Italian, Japanese, and French.
Where does Alfred Scheidegger work?: Alfred Scheidegger is Managing Partner at Nextech Invest and Board director at Cleave Biosciences.
What check size does Alfred Scheidegger write?: Alfred Scheidegger typically writes checks of $100K – $5M.
What boards does Alfred Scheidegger sit on?: Alfred Scheidegger holds tracked board seats at Cleave Biosciences.
Where did Alfred Scheidegger go to school?: Alfred Scheidegger studied at Harvard Business School (The General Manager, Business Administration and Management); Kyoto University (Postdoc in Enzymology); Biozentrum, University of Basel (Doctor of Philosophy (PhD), Biochemistry and Microbiology).

Same school

Also attended Harvard Business School2,000

Brad GerstnerFounder & CEO of Altimeter Capital Aileen LeeFounder & Managing Partner of Cowboy Ventures Jim BreyerFounder & CEO of Breyer Capital Tim DraperFounder of Draper Associates Mike Maples JrCo-founding Partner at Floodgate Mamoon HamidPartner at Kleiner Perkins

+ 1,994 more

Also attended Kyoto University53

Taro InabaManaging Partner at Remiges Ventures, Inc.Kazuhiko NonomuraPartner at Remiges Ventures, Inc.Sunao NishimuraInvestor at E12 Venture Capital, Llc Yoshiharu UrunoInvestor at JIC Venture Growth Investments Melody MadhavanAssociate at Cento Ventures Kotaro SasamotoManaging Partner at Dentsu Ventures

+ 47 more

Also attended Biozentrum, University of Basel3

Diego BragugliaManaging Partner at VI Partners Anne GrahlAssociate at Pureos Bioventures Eric LagasseExecutive Officer, Director at Lygenesis

Also attended University of Basel38

Markus GemuendSenior Advisor at Adjuvant Capital Michel BriejerManaging Partner at Thuja Capital Butrint AliuAnalyst at Pureos Bioventures Nadine KuglerHead of Tech Communications at QAI Ventures Davide OttoliniCo-founder at Korify Capital Robin LauberInvestor at Korify Capital

+ 32 more

Shared employers

Also worked at Nextech Invest Ltd.13

Richard HeymanVenture Partner at ARCH Venture Partners Stella PaffenholzSenior Associate at Atlas Venture Jakob LovenPartner at Nextech Invest Alexis BorisyOperating Chairman at Curie.Bio Gabriele CampiImmunologist / Technology Transfer at Aurora Science Kristina BeelerScientific Advisory Board; Chief Business Officer at Biognosys, PhD at Biovance Capital Partners SCR

+ 7 more